The newly-developed Ancamide® 2853 & 2865 sustainable epoxy curing agents from Evonik can deliver good flexibility, strength and fast curing speed for the coatings industry.
The specialty chemicals manufacturer Evonik has recently added two new polyamide-based epoxy curing agents to its portfolio: Ancamide® 2853 and Ancamide® 2865 provide the paints and coatings industry with innovative and high-performance solutions.
Ancamide 2853 and Ancamide 2865 can deliver high flexibility with standard diluted epoxy resin, eliminating the need for polyurethane modifiers. Indeed, these curing agents offer high tensile and tear strength, as well as fast curing speeds, therefore making them ideal for applications requiring quick return to service. Additionally, they are nonylphenol-free and use bio-based raw materials with a bio-content of 20-40%, making them safer and more eco-friendly.
"Our customers are navigating stricter labelling requirements, and we are dedicated to providing solutions that not only meet these standards, but also deliver the exceptional performance they rely on. By utilizing bio-based raw materials, these nonylphenol-free products offer a safer and more eco-friendly option, exemplifying our commitment to innovation and sustainability,” has stated Kevin Wohlhauser, Regional Head of the Civil Engineering market segment of Evonik Crosslinkers in the Americas.
Moreover, both of these new curing agents are ideal for civil engineering and flooring applications where
coatings are subjected to frequent movement and stress. Their fast-curing speed reduces downtime, making them suitable for deck overlays, flexible membranes, crack bridging, joint sealants, and flexible grouts.
"In addition to being ideal for applications requiring rapid turnaround times, our customers also find Ancamide 2853 and Ancamide 2865 very easy to use. Formulators have maximum flexibility to customize their products by adjusting the mix ratio of part A and part B,” has added Shiying Zheng, Regional Applied Technology Director of the Civil Engineering market segment of Evonik Crosslinkers in the Americas.